首页 > 市场调查报告书 > 医疗设备

e保健医院 IT

市场调查报告书

商品编码

1542475

全球临床决策支援系统市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Clinical Decision Support System Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球临床决策支援系统市场需求预计将从2023年的58.3亿美元达到2032年近154.9亿美元的市场规模，2024-2032年研究期间的复合年增长率为11.46%。

临床决策支援系统（CDSS）是一种医疗保健资讯科技工具，旨在协助医疗保健专业人员完成临床决策任务。 CDSS 整合了来自电子健康记录 (EHR)、医学知识库和临床指南的患者资料，以在护理点提供基于证据的建议和警报。它分析患者的特定讯息，例如实验室结果、病史和当前用药，以支持诊断和治疗决策。 CDSS 旨在透过减少医疗错误、优化资源利用率以及促进遵守最佳实践和临床方案来改善临床结果、病患安全和工作流程效率。

市场动态

电子健康记录和互通性标准的日益普及鼓励将临床决策支援系统整合到医疗保健工作流程中，从而促进跨护理环境无缝存取患者资料和决策支援工具。 CDSS 解决方案利用人工智慧 (AI)、机器学习 (ML) 和自然语言处理 (NLP) 演算法来分析大量资料集、预测临床结果并根据患者特定特征提出个人化治疗建议。监管措施和医疗改革促进 CDSS 的使用，以改善护理协调、降低医疗成本并减少医疗差错。 CDSS 与远距医疗平台和行动医疗应用程式的整合支援远端患者监控、虚拟咨询和个人化健康管理，从而增强患者参与度和护理连续性。

此外，临床资讯学、巨量资料分析和云端运算的进步推动了临床决策支援系统功能的创新，实现了即时决策支援、临床路径优化和人口健康管理。市场机会包括扩大 CDSS 在慢性病管理、精准医疗计划和临床试验中的应用，其中预测分析和决策支援工具可以简化复杂的决策过程并改善治疗结果。然而，不同医疗保健 IT 系统之间的互通性障碍、资料隐私问题以及医疗保健提供者之间对变革的抵制等挑战可能会阻碍临床决策支援系统市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球临床决策支援系统市场的各个细分市场进行了包容性评估。临床决策支援系统产业的成长和趋势为本研究提供了整体方法。

市场区隔

临床决策支援系统市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

独立CDSS
整合 CPOE 与 CDSS
与 CDSS 整合 EHR
与 CPOE 和 EHR 整合的 CDSS

按申请

药物间相互作用
药物过敏警报
临床提醒
临床指引
药物剂量支持
其他的

按交付方式

网路为基础的系统
基于云端的系统
本地系统

按组件

硬体
软体
服务

区域分析

本节涵盖区域展望，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲临床决策支援系统市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。临床决策支援系统市场的主要参与者包括 McKesson Corporation、Oracle (Cerner Corporation)、Siemens Healthineers GmbH、Allscripts Healthcare LLC、Athenahealth Inc.、NextGen Healthcare Inc.、Koninklijke Philips NV IBM、Agfa-Gevaert Group、Wolters Kluwer NV本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业动态
波特五力分析
市场吸引力分析
- 按产品分類的市场吸引力分析
- 市场吸引力分析：依应用分类
- 按交付模式分類的市场吸引力分析
- 按组件分類的市场吸引力分析
- 市场吸引力分析：按地区

第 4 章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球临床决策支援系统市场分析：按产品

概述（按产品）
按产品分类的历史和预测资料分析
独立CDSS
整合 CPOE 与 CDSS
与 CDSS 整合 EHR
与 CPOE 和 EHR 整合的 CDSS

第 6 章：全球临床决策支援系统市场分析：按应用分类

概述：按应用
历史和预测数据分析：按应用
药物间相互作用
药物过敏警报
临床提醒
临床指引
药物剂量支持
其他的

第 7 章：全球临床决策支援系统市场分析：按交付模式

按交付模式概述
按交付模式进行历史和预测资料分析
网路为基础的系统
基于云端的系统
本地系统

第 8 章：全球临床决策支援系统市场分析：按组成部分

按组件概述
按组成部分的历史和预测资料分析
硬体
软体
服务

第 9 章：全球临床决策支援系统市场分析：依地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 10 章：临床决策支援系统公司的竞争格局

临床决策支援系统市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 11 章：公司简介

顶级公司市占率分析
市场集中度
McKesson Corporation

公司概况
公司收入
产品
最新动态

Oracle (Cerner Corporation)

公司概况
公司收入
产品
最新动态

Siemens Healthineers GmbH

公司概况
公司收入
产品
最新动态

Allscripts Healthcare LLC

公司概况
公司收入
产品
最新动态

Athenahealth Inc.

公司概况
公司收入
产品
最新动态

NextGen Healthcare Inc.

公司概况
公司收入
产品
最新动态

Koninklijke Philips NV IBM

公司概况
公司收入
产品
最新动态

Agfa-Gevaert Group

公司概况
公司收入
产品
最新动态

Wolters Kluwer NV

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11212597

The global demand for Clinical Decision Support System Market is presumed to reach the market size of nearly USD 15.49 Billion by 2032 from USD 5.83 Billion in 2023 with a CAGR of 11.46% under the study period 2024-2032.

A clinical decision support system (CDSS) is a healthcare information technology tool designed to assist healthcare professionals in clinical decision-making tasks. CDSS integrates patient data from electronic health records (EHRs), medical knowledge bases, and clinical guidelines to provide evidence-based recommendations and alerts at the point of care. It analyzes patient-specific information, such as lab results, medical history, and current medications, to support diagnostic and treatment decisions. CDSS aims to improve clinical outcomes, patient safety, and workflow efficiency by reducing medical errors, optimizing resource utilization, and promoting adherence to best practices and clinical protocols.

MARKET DYNAMICS

The increasing adoption of electronic health records and interoperability standards encourages the integration of clinical decision-support systems into healthcare workflows, facilitating seamless access to patient data and decision-support tools across care settings. CDSS solutions leverage artificial intelligence (AI), machine learning (ML), and natural language processing (NLP) algorithms to analyze vast datasets, predict clinical outcomes, and personalize treatment recommendations based on patient-specific characteristics. Regulatory initiatives and healthcare reforms promote the use of CDSS to improve care coordination, reduce healthcare costs, and mitigate medical errors. Integration of CDSS with telehealth platforms and mobile health applications supports remote patient monitoring, virtual consultations, and personalized health management, enhancing patient engagement and continuity of care.

Moreover, advancements in clinical informatics, big data analytics, and cloud computing drive innovation in clinical decision support system capabilities, enabling real-time decision support, clinical pathway optimization, and population health management. Opportunities in the market include expanding CDSS applications in chronic disease management, precision medicine initiatives, and clinical trials, where predictive analytics and decision support tools streamline complex decision-making processes and improve treatment outcomes. However, challenges such as interoperability barriers between disparate healthcare IT systems, data privacy concerns, and resistance to change among healthcare providers may hinder the clinical decision support system market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Clinical Decision Support System. The growth and trends of Clinical Decision Support System industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Clinical Decision Support System market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Standalone CDSS
Integrated CPOE with CDSS
Integrated EHR with CDSS
Integrated CDSS with CPOE & EHR

By Application

Drug-Drug Interactions
Drug Allergy Alerts
Clinical Reminders
Clinical Guidelines
Drug Dosing Support
Others

By Delivery Mode

Web-Based Systems
Cloud-Based Systems
On -Premise Systems

By Component

Hardware
Software
Services

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Clinical Decision Support System market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Clinical Decision Support System market include McKesson Corporation, Oracle (Cerner Corporation), Siemens Healthineers GmbH, Allscripts Healthcare LLC, Athenahealth Inc., NextGen Healthcare Inc., Koninklijke Philips N.V. IBM, Agfa-Gevaert Group, Wolters Kluwer N.V. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CLINICAL DECISION SUPPORT SYSTEM - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Delivery Mode
- 3.7.4 Market Attractiveness Analysis By Component
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Standalone CDSS Historic and Forecast Sales By Regions
5.4. Integrated CPOE with CDSS Historic and Forecast Sales By Regions
5.5. Integrated EHR with CDSS Historic and Forecast Sales By Regions
5.6. Integrated CDSS with CPOE & EHR Historic and Forecast Sales By Regions

6. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Drug-Drug Interactions Historic and Forecast Sales By Regions
6.4. Drug Allergy Alerts Historic and Forecast Sales By Regions
6.5. Clinical Reminders Historic and Forecast Sales By Regions
6.6. Clinical Guidelines Historic and Forecast Sales By Regions
6.7. Drug Dosing Support Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET ANALYSIS BY DELIVERY MODE

7.1. Overview By Delivery Mode
7.2. Historical and Forecast Data Analysis By Delivery Mode
7.3. Web-Based Systems Historic and Forecast Sales By Regions
7.4. Cloud-Based Systems Historic and Forecast Sales By Regions
7.5. On -Premise Systems Historic and Forecast Sales By Regions

8. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET ANALYSIS BY COMPONENT

8.1. Overview By Component
8.2. Historical and Forecast Data Analysis By Component
8.3. Hardware Historic and Forecast Sales By Regions
8.4. Software Historic and Forecast Sales By Regions
8.5. Services Historic and Forecast Sales By Regions

9. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE CLINICAL DECISION SUPPORT SYSTEM COMPANIES

10.1. Clinical Decision Support System Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF CLINICAL DECISION SUPPORT SYSTEM INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. McKesson Corporation
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Oracle (Cerner Corporation)
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Siemens Healthineers GmbH
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Allscripts Healthcare LLC
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Athenahealth Inc.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. NextGen Healthcare Inc.
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Koninklijke Philips N.V. IBM
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Agfa-Gevaert Group
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Wolters Kluwer N.V
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments